Target Ovarian Cancer won a Charter Champion Award at the inaugural World Ovarian Cancer Coalition Impact Awards. This award recognises our work during the pandemic to ensure that the needs of those with ovarian cancer continued to be met.
Our ovarian cancer mini guides were commended at the British Medical Association (BMA) Patient Information Awards. Three guides ('Ovarian cancer, sex and intimacy', 'Ovarian cancer and your finances' and 'Ovarian cancer and complementary therapies') were submitted under the banner 'living well with ovarian cancer mini guides'.
Our 'My care, my future' guide and our symptoms awareness campaign were both awarded British Medical Association (BMA) Patient Information Awards. The guide was hailed by the judges as "one of the best booklets on a medical topic I have ever read" and also received runner-up in the special additional category of User Engagement.
Target Ovarian Cancer was announced the winner of a special GSK IMPACT Award in 2017, the 20th Anniversary Award. All overall winners of the GSK IMPACT Award since 2010 were shortlisted. The awards recognise charities that have made an outstanding contribution to improving health and wellbeing in the UK. They are funded by GlaxoSmithKline and managed in partnership with The King's Fund.
Target Ovarian Cancer was selected as a finalist for the Excellence in Media Relations – Healthcare award at the Communique 2017 awards for healthcare communications for our work on our Pathfinder report.
Our genetic testing and hereditary ovarian cancer guide won two awards in the British Medical Association's (BMA) Patient Information Awards. The guide won a special award for patient information on screening and came runner up in the award for information on ethical issues.
Target Ovarian Cancer was awarded the Best Ovarian Cancer Support Agency – UK award at the 2017 International Life Sciences Awards by Global Health and Pharma magazine.
Target Ovarian Cancer's joint guide 'A younger woman's guide to ovarian cancer' won a British Medical Association (BMA) Patient Information Award and came runner up in the special category for information about long term conditions.
Target Ovarian Cancer's website was recognised with a Women's Health Blog Award 2016 – an award for blogs, websites and charities that help to support and empower women, selected by a panel of experts and coordinated by HealthExpress.
Target Ovarian Cancer's symptoms leaflet won a British Medical Association (BMA) Patient Information Award 2015. Our symptoms leaflet is one of our core pieces of information to help improve early diagnosis for women concerned about symptoms.
The Third Sector Excellence Awards recognise those who give back to the community and celebrate organisations and social leaders from across the sector. In 2015, our Chair Joanna Barker was nominated for Charity Chair of the Year, and our ambassador Annie Mulholland was nominated for Volunteer of the Year.
Our online Clinical Trials Information Centre won a 'Special award for user involvement' at the British Medical Association Awards. Looking after me, our guide which aims to improve the quality of life of women with ovarian cancer that is terminal or life-limiting, was also highly commended.
The Charity Times Awards celebrate best practice in the UK charity and not-for-profit sector. In 2015, we were shortlisted for 'Best use of web' for our website. We are particularly proud of the role that women with ovarian cancer had in developing our new site (launched in 2014) – both in shaping its structure and in featuring throughout the content. Since launch, the number of people visiting our site to get support and information has significantly increased.
Target Ovarian Cancer’s Clinical Trials Information Centre won 'Best entry from a small charity (for charities with a research spend under £1m)' at the AMRC Science Communication Awards 2014. It was also runner up for ‘Online and social media’. The Clinical Trials Information Centre is an online tool that allows women with ovarian cancer to quickly and easily search for clinical trials that could benefit them. It was praised for its layout and intuitiveness, and for providing much-needed information, clearly tailored to its target audience.
Target Ovarian Cancer was overall winner of the 2012 GSK IMPACT Awards, for our work improving survival and quality of life for women with ovarian cancer across the UK.
Target Ovarian Cancer's BMJ Learning module for GPs was highly commended in the 'Best professional education' category at the Excellence in Oncology Awards in 2010.
The free online tool enables GP to update their knowledge on ovarian cancer symptoms through an interactive hour-long course. The judges commented that it showed great potential to influence the diagnosis of ovarian cancer.
Keep in touch
Sign up to receive emails and keep up to date on all things Target Ovarian Cancer